Drreddys Laboratories | RDY - Equity Capital And Reserves


Drreddys Laboratories reported INR4.14B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
ANI Pharmaceuticals USD 562.3M 21.58M Mar/2026
Aurora Cannabis CAD 536.36M 30.74M Dec/2025
Bayer EUR 28.85B 2.9B Mar/2026
Canopy Growth CAD 758.17M 22.16M Dec/2025
Cipla INR 344.32B 15.13B Mar/2026
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
GlaxoSmithKline GBP 17.42B 1.05B Mar/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Novartis USD 38.93B 7.2B Mar/2026
Pacira USD 653.89M 39.22M Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 1.89B 58.06M Mar/2026
Richter Gedeon HUF 1.46T 59.22B Mar/2026
Sun Pharmaceuticals INR 835.7B 57.5B Mar/2026
Supernus Pharmaceuticals USD 1.08B 15.09M Mar/2026
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026